Health and Healthcare
319 Articles
ThinkstockDrug developer Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) watched its shares plummet 35% yesterday following a report that rheumatoid arthritis treatment…
ThinkstockOn December 7, marijuana became legal in the state of Washington, adding to the list of states that have moved…
As corporate earnings are disappointing and as the economy remains very sluggish, companies are announcing big waves of layoffs. Some…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations we have seen from Wall St. research calls…
The three major U.S. stock indexes opened lower this morning, and never really got untracked all day. Spanish 10-year bond…
Abbott Laboratories (NYSE: ABT) said that third-quarter earnings surged, despite a slip in revenue, due to a double-digit decline in…
The three major U.S. stock indexes opened higher this morning following a report that economic sentiment in Germany came in…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…
The quarterly ExpertRECALL Index released today indicates that more than 123 million medical device units were recalled during the second…
The press recently had a field day with a report from the “Institute for Policy Studies” about executive pay. The…
Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp.…
At the end of two weeks of non-stop second quarter earnings reports, S&P Capital IQ expects a decline of -0.71%…
The three major US stock indexes opened modestly lower this morning as there was little news out of Europe and…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…
Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…
Our top personal finance-related articles today. Your wallet will thank you later.